The approval is based on data from one pivotal Phase III study (AK111-301) and three additional supportive studies.

Based on this data and data from two other Phase III trials, Takeda will file for the approval of zasocitinib in PsA.

June 11 (Reuters) - Japan's Takeda Pharmaceutical said on Thursday its experimental once-daily psoriasis pill, developed with ...

—A growing body of evidence has revealed several comorbidities associated with generalized plaque psoriasis. A new study takes a closer look at possible shared risks for a subtype, palmoplantar ...

Akeso, Inc. (9926.HK) today announced that the National Medical Products Administration (NMPA) of China has approved gumokimab (AK111), the company's internally-developed anti-IL-17 monoclonal ...

Getting a plaque psoriasis diagnosis should be a pretty straightforward process. You see a dermatologist, who looks for the telltale scaly patches on your skin. But diagnosis may not be as direct or ...

Takeda (TSE:4502/NYSE:TAK) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study ...

Over 8 million adults in the U.S. experience plaque psoriasis — a chronic autoimmune disease that causes painful, raised, scaly spots on the skin. People with plaque psoriasis often employ a host of ...

Plaque psoriasis is a long-lasting skin condition that causes thick, scaly patches (plaques) on the skin. It happens when your immune system becomes overactive and speeds up the growth of skin cells.

ICONIC-LEAD is the first ever Phase 3 registrational study in moderate-to-severe plaque psoriasis to assess safety and efficacy of a systemic therapy in adolescents and adults simultaneously 84% of ...

Psoriasis is associated with an increased prevalence of high-risk coronary plaques and risk of future cardiovascular events. In a retrospective observational study, lipid rich necrotic core (LRNC), a ...

Dallas Goedert enters each Eagles game hoping to focus solely the task at hand — beating whatever team the Birds are playing that day. But to do so, he must manage his plaque psoriasis, a chronic skin ...